Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2019

01-10-2019 | Lymphoma | Original Article

Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps

Authors: Hamzah Abu-Sbeih, Ellie Chen, Osman Ahmed, Niharika Mallepally, Phillip Lum, Wei Qiao, Hun Ju Lee, Robert Bresalier, Lan Sun Wang, Brian Weston, Gottumukkala S. Raju, Yinghong Wang

Published in: Digestive Diseases and Sciences | Issue 10/2019

Login to get access

Abstract

Background

Patients with non-Hodgkin’s lymphoma (NHL) are frequently referred for colonoscopy to evaluate gastrointestinal symptoms during their treatment course. Here, we described the rate of colonic adenomas in patients with NHL.

Methods

This was a retrospective study of patients with NHL who underwent colonoscopy after being diagnosed with NHL between January 2000 and December 2017.

Results

Of the 17,938 patients who had been diagnosed with NHL in the study period, 2176 met the inclusion criteria. The mean age at the time of colonoscopy was 61 years. Most patients were male (61%). Overall, 1273 polyps were detected in 811 patients (37%). Sessile serrated adenomas were detected in 102 (5%) patients. The overall ADR was 12% in patients younger than 40 years of age (n = 103), 26% in patients aged 40–50 (n = 251), 34% in patients aged 51–60 (n = 630), and 43% in patients older than 60 (n = 1212). Most polyps were located in the right colon (63%), and 101 (8%) were larger than 1 cm. Villous adenomatous features were present in 1% of polyps, while high-grade dysplasia was detected in 22%. Invasive adenocarcinoma was identified in 4%. The median interval from lymphoma diagnosis to adenoma detection was 1.4 years (interquartile range 0.5–3.8 years). A repeat colonoscopy was performed in 343 patients. The overall ADR on repeat colonoscopy was 30%. Cox regression analysis revealed that age (hazards ratio 1.04; 95% confidence interval 1.03–1.05; P < 0.001) and male sex (hazards ratio 1.35; 95% confidence interval 1.13–1.60; P = 0.001) were independent factors associated with worse overall survival. By contrast, screening colonoscopy was associated with longer survival duration (hazards ratio 0.48; 95% confidence interval 0.36–0.63; P < 0.001).

Conclusion

The ADR in NHL patients aged 40–50 years was equivalent to that reported in the literature in non-cancer patients aged 50–70 years. Early screening colonoscopy may be warranted in NHL patients younger than 50 years. Screening colonoscopy significantly improved the overall survival of patients with NHL.
Appendix
Available only for authorised users
Literature
3.
go back to reference Stewart SLWJ, Kato I. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107:1128–1141.CrossRefPubMed Stewart SLWJ, Kato I. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107:1128–1141.CrossRefPubMed
4.
go back to reference Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis. 2000;11:229–237.PubMed Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis. 2000;11:229–237.PubMed
5.
go back to reference Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem. 1992;16g:41–46.CrossRef Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem. 1992;16g:41–46.CrossRef
6.
go back to reference Brenner HHM, Stegmaier C. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56:1585–1589.CrossRefPubMedPubMedCentral Brenner HHM, Stegmaier C. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56:1585–1589.CrossRefPubMedPubMedCentral
7.
go back to reference Hisabe THF, Matsui T. Development and progression of colorectal cancer based on follow-up analysis. Dig Endosc. 2014;26:73–77.CrossRefPubMed Hisabe THF, Matsui T. Development and progression of colorectal cancer based on follow-up analysis. Dig Endosc. 2014;26:73–77.CrossRefPubMed
8.
go back to reference Winawer SJFR, Miller L. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594.CrossRefPubMed Winawer SJFR, Miller L. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594.CrossRefPubMed
10.
go back to reference Zauber AGWS, O’Brien MJ. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEJM. 2012;366:687–696.CrossRefPubMed Zauber AGWS, O’Brien MJ. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEJM. 2012;366:687–696.CrossRefPubMed
15.
16.
go back to reference Force UPST. Screening for colorectal cancer, US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.CrossRef Force UPST. Screening for colorectal cancer, US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.CrossRef
17.
go back to reference Society AC. Colorectal cancer facts and figures 2017–2019. In: Society AC, ed. Atlanta; 2017. p. 11–15. Society AC. Colorectal cancer facts and figures 2017–2019. In: Society AC, ed. Atlanta; 2017. p. 11–15.
19.
go back to reference Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–89.CrossRefPubMed Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–89.CrossRefPubMed
20.
go back to reference Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.CrossRef Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.CrossRef
21.
23.
go back to reference Strul HKR, Leshno M. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed Strul HKR, Leshno M. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed
24.
go back to reference Hemmasi GSM, Zamani F. Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years. Eur J Cancer Prev. 2015;24:386–390.CrossRefPubMed Hemmasi GSM, Zamani F. Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years. Eur J Cancer Prev. 2015;24:386–390.CrossRefPubMed
25.
go back to reference Diamond SJEB, Jiang Z. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc. 2011;74:135–140.CrossRefPubMed Diamond SJEB, Jiang Z. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc. 2011;74:135–140.CrossRefPubMed
26.
go back to reference Facciorusso ADMM, Serviddio G. Factors associated with recurrence of advanced colorectal adenoma after endoscopic resection. Clin Gastroenterol Hepatol. 2016;14:1148–1154.CrossRefPubMed Facciorusso ADMM, Serviddio G. Factors associated with recurrence of advanced colorectal adenoma after endoscopic resection. Clin Gastroenterol Hepatol. 2016;14:1148–1154.CrossRefPubMed
27.
go back to reference Bonithon-Kopp CPF, Fenger C. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–333.CrossRefPubMed Bonithon-Kopp CPF, Fenger C. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–333.CrossRefPubMed
28.
go back to reference Jang ESKJ, Jung YJ. Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol. 2013;24:476–482.CrossRefPubMed Jang ESKJ, Jung YJ. Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol. 2013;24:476–482.CrossRefPubMed
30.
go back to reference Baras NDS, Haberland J. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990–2012). Br J Haematol. 2017;177:226–242.CrossRefPubMed Baras NDS, Haberland J. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990–2012). Br J Haematol. 2017;177:226–242.CrossRefPubMed
31.
go back to reference Rossi CJJ, Mounier M. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56:2876–2882.CrossRefPubMed Rossi CJJ, Mounier M. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56:2876–2882.CrossRefPubMed
Metadata
Title
Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps
Authors
Hamzah Abu-Sbeih
Ellie Chen
Osman Ahmed
Niharika Mallepally
Phillip Lum
Wei Qiao
Hun Ju Lee
Robert Bresalier
Lan Sun Wang
Brian Weston
Gottumukkala S. Raju
Yinghong Wang
Publication date
01-10-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05629-z

Other articles of this Issue 10/2019

Digestive Diseases and Sciences 10/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.